WEBINAR: Equipment Design and Considerations in Cell Therapy Processes
19 May 2026 | 5.30-6.30pm SGT | Online
Hosted by the ISPE APAC ATMP Community of Practice
ABSTRACT
- Evolution of process technology and future trends in cell therapy manufacturing
- Automation and digitization considerations for cell therapy processes
- Specific requirements to analytics and lab equipment for cell therapy
LED BY
Judith Koliwer, PhD, Senior Industry Advisor and Principal Consultant Advanced Therapies, Körber Pharma Software
After her PhD on the genetic background of autism spectrum disorders, Judith was leading an academic research group, which analyzed the physiological role of proteins associated with cancer and epilepsy by using lenti and retroviral transduction for genetic modification of cell cultures. In 2019, Judith joined the MES and data analytics company Körber Pharma Software as senior industry advisor and principal consultant for advanced therapies. Since 2021, she is leading the company’s strategy on solutions for digital transformation in cell and gene therapies and is actively shaping the industry with her leadership of the ISPE CoP on Digitization of Cell and Gene Therapies, as well as contributions with BioPhorum and individual publications.
Stephen Judd, European Director of Process Technology, Arcadis
Stephen is a Chartered Chemical Engineer, IChemE Fellow, Fellow of Engineers Ireland and has over 20 years’ experience in process engineering and facility design. He is the European Director of Process Technology where he has responsibility for management and development of the SME structure associated with Arcadis’ European operations as well as advising in early project stages. Stephen is passionate about learning and development and supports the chemical / biochemical engineering departments of several universities. He frequently presents at industry events and conferences and has authored or co-authored technical papers including a paper on Multi-Modal Facility Design published in the ISPE PE Magazine (winner of the 2023 Roger F. Sherwood article of year award).